PMV Pharmaceuticals annual net debt
2021
2022
2023
2024
2025
PMV Pharmaceuticals Net Debt Growth & History (PMVP)
PMV Pharmaceuticals's net debt was −$37.1M for fiscal 2025.
View full PMV Pharmaceuticals company overviewPMV Pharmaceuticals annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$37.1M | $2.5M | — |
| 2024 | 2024-12-31 | −$39.7M | −$15.3M | — |
| 2023 | 2023-12-31 | −$24.4M | $69.9M | — |
| 2022 | 2022-12-31 | −$94.3M | $67.0M | — |
| 2021 | 2021-12-31 | −$161.3M | — | — |
PMV Pharmaceuticals quarterly net debt
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$12.3M | $30.9M | — |
| Q1 2026 | 2026-03-31 | −$38.8M | $11.4M | — |
| Q4 2025 | 2025-12-31 | −$37.1M | $2.5M | — |
| Q3 2025 | 2025-09-30 | −$35.4M | $137,000 | — |
| Q2 2025 | 2025-06-30 | −$43.1M | −$7.6M | — |
| Q1 2025 | 2025-03-31 | −$50.2M | −$15.6M | — |
| Q4 2024 | 2024-12-31 | −$39.7M | −$15.3M | — |
| Q3 2024 | 2024-09-30 | −$35.5M | $3.8M | — |
| Q2 2024 | 2024-06-30 | −$35.5M | $19.7M | — |
| Q1 2024 | 2024-03-31 | −$34.6M | $94.8M | — |
| Q4 2023 | 2023-12-31 | −$24.4M | $69.9M | — |
| Q3 2023 | 2023-09-30 | −$39.4M | $48.0M | — |
| Q2 2023 | 2023-06-30 | −$55.2M | $19.3M | — |
| Q1 2023 | 2023-03-31 | −$129.5M | −$25.4M | — |
| Q4 2022 | 2022-12-31 | −$94.3M | $67.0M | — |
| Q3 2022 | 2022-09-30 | −$87.3M | $78.1M | — |
| Q2 2022 | 2022-06-30 | −$74.5M | $103.7M | — |
| Q1 2022 | 2022-03-31 | −$104.0M | $103.8M | — |
| Q4 2021 | 2021-12-31 | −$161.3M | — | — |
| Q3 2021 | 2021-09-30 | −$165.4M | — | — |
| Q2 2021 | 2021-06-30 | −$178.2M | — | — |
| Q1 2021 | 2021-03-31 | −$207.8M | — | — |
PMV Pharmaceuticals net debt trends
Between the periods ended 2021-12-31 and 2025-12-31, PMV Pharmaceuticals's net debt increased from −$161.3M to −$37.1M, a change of $124.1M. The latest reported quarter, Q2 2026, shows −$12.3M.
About the metric
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
Calculation and source
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review PMV Pharmaceuticals source filings ↗